Literature DB >> 2404624

Is physiologic sympathoadrenal catecholamine release exocytotic in humans?

M A Takiyyuddin1, J H Cervenka, P A Sullivan, M R Pandian, R J Parmer, J A Barbosa, D T O'Connor.   

Abstract

In cultured cells and isolated perfused organs, catecholamines are coreleased with chromogranin A (CgA) from adrenal chromaffin cells and sympathetic neurons. The corelease suggests that exocytosis is the mechanism of catecholamine secretion. To investigate whether physiologic catecholamine secretion is exocytotic in humans, we measured plasma norepinephrine, epinephrine, and CgA responses to differentiated stimuli of sympathoadrenal discharge. The CgA radioimmunoassay antibody recognized authentic CgA in normal human adrenal chromaffin vesicles. Insulin-induced hypoglycemia and caffeine ingestion, in decreasing order of potency, selectively stimulated epinephrine release from the adrenal medulla. During hypoglycemia, plasma levels of epinephrine and CgA rose, and peak plasma levels of epinephrine and CgA correlated, suggesting that gradations in epinephrine release represented gradations in exocytosis. However, significant increments in plasma CgA were not observed after caffeine ingestion. Furthermore, the rise of CgA levels during hypoglycemia lagged 60 minutes behind those of epinephrine. A less-pronounced temporal dissociation between CgA and epinephrine release was also shown in isolated chromaffin cells in vitro. Selective adrenal vein catheterization suggested a barrier to CgA transport across the adrenal capillary wall. Short-term, high-intensity dynamic exercise, assumption of the upright posture, prolonged low-intensity dynamic exercise, and smoking, in decreasing order of potency, stimulated norepinephrine release from sympathetic nerve endings. Only the first sympathetic neuronal stimulus resulted in significant increments in plasma CgA, increments considerably less than those attained during adrenal medullary activation by insulin hypoglycemia. During high-intensity exercise, peak plasma norepinephrine and CgA levels correlated, suggesting that gradations in norepinephrine release represented gradations in exocytosis. The human adrenal medulla was a far more prominent tissue source of CgA than human sympathetic nerves--adrenal medullary homogenates contained 97-fold more CgA (micrograms/g) than sympathetic nerve homogenates. In conclusion, catecholamine secretion during selective stimulation of either sympathetic nerves or the adrenal medulla is, at least in part, exocytotic. Furthermore, stimulation of the former results in comparatively modest changes in plasma CgA compared with changes attained during stimulation of the latter. CgA appears to be transported by a route different from that of catecholamines from adrenal medullary chromaffin cells to the circulation in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404624     DOI: 10.1161/01.cir.81.1.185

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

Review 1.  Heredity and the autonomic nervous system in human hypertension.

Authors:  D T O'Connor; P A Insel; M G Ziegler; V Y Hook; D W Smith; B A Hamilton; P W Taylor; R J Parmer
Journal:  Curr Hypertens Rep       Date:  2000-02       Impact factor: 5.369

Review 2.  Catestatin: a multifunctional peptide from chromogranin A.

Authors:  Sushil K Mahata; Manjula Mahata; Maple M Fung; Daniel T O'Connor
Journal:  Regul Pept       Date:  2010-01-28

3.  Physiological stimulation regulates the exocytic mode through calcium activation of protein kinase C in mouse chromaffin cells.

Authors:  Tiberiu Fulop; Corey Smith
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

4.  Primary culture of bovine chromaffin cells.

Authors:  Daniel T O'Connor; Sushil K Mahata; Manjula Mahata; Qijiao Jiang; Vivian Y Hook; Laurent Taupenot
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

5.  Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

Authors:  Nitish R Mahapatra; Daniel T O'Connor; Sucheta M Vaingankar; Amiya P Sinha Hikim; Manjula Mahata; Saugata Ray; Eugenie Staite; Hongjiang Wu; Yusu Gu; Nancy Dalton; Brian P Kennedy; Michael G Ziegler; John Ross; Sushil K Mahata
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

6.  Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin.

Authors:  Nilima Biswas; Sucheta M Vaingankar; Manjula Mahata; Madhusudan Das; Jiaur R Gayen; Laurent Taupenot; Justin W Torpey; Daniel T O'Connor; Sushil K Mahata
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

Review 7.  Chromogranin A: a novel susceptibility gene for essential hypertension.

Authors:  Bhavani S Sahu; Parshuram J Sonawane; Nitish R Mahapatra
Journal:  Cell Mol Life Sci       Date:  2009-11-27       Impact factor: 9.261

8.  Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway.

Authors:  R J Parmer; X P Xi; H J Wu; L J Helman; L N Petz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Identification of marker proteins by orthodontic treatment: relationship of RANKL in the gingival crevicular fluid and of amylase in whole saliva with orthodontic treatment.

Authors:  Hiroo Kuroki; Yukio Miyagawa; Junko Shimomura-Kuroki; Toshiya Endo; Hiromi Shimomura
Journal:  Odontology       Date:  2013-07-18       Impact factor: 2.634

10.  Mechanism of action of chromogranin A on catecholamine release: molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity.

Authors:  I Tsigelny; S K Mahata; L Taupenot; N E Preece; M Mahata; I Khan; R J Parmer; D T O'Connor
Journal:  Regul Pept       Date:  1998-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.